DigestRedComo funciona
Red
/
Empresas
Cl
No verificado

ClearNote Health

Sobre qué escribimos

BiotecnologíaIndustriaMedicina - VariosOncologíaSalud

17 Comunicados de prensa

Ver todos los comunicados de prensa
27/05/2026
Mercado laboral
Eventos
Ferias y Congresos
Asociaciones/Profesionales
Oncología
Salud
Finanzas
Biotecnología
ClearNote Health Secures $52 Million in Series D Financing and Strengthens Leadership Team to Accelerate Growth in Early Cancer Detection
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
22/05/2026
Eventos
Industria
Biotecnología
Salud
Oncología
ClearNote Health to Present Early Detection Validation Data for Avantect® Pancreatic Cancer Test at 2026 ASCO Annual Meeting
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
29/04/2026
Eventos
Industria
Ciencia
Material médico sanitario
Medicina - Varios
Salud
Farmacéutica
Sanidad
Oncología
ClearNote Health to Present Industry-Leading Early Detection Data for Avantect® Pancreatic Cancer Test at Digestive Disease Week 2026
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
15/04/2026
Ciencia
Material médico sanitario
Medicina - Varios
Salud
Farmacéutica
Sanidad
Oncología
ClearNote Health to Showcase Industry-Leading Early Detection Performance of the Avantect® Pancreatic Cancer Test at AACR Annual Meeting 2026
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
18/03/2026
Sanidad
Salud
Ciencia
Mercado laboral
ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team to Drive Clinical Adoption of Early Cancer Detection Tests
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
23/02/2026
Industria
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Oncología
ClearNote Health’s Enhanced Avantect® Pancreatic Cancer Test Delivers Industry-Leading Early Detection Performance
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
17/10/2025
Ciencia
Oncología
Técnica
Material médico sanitario
Biotecnología
Medicina - Varios
Cardiología
Salud
Eventos
ClearNote Health to Showcase Latest Advancements in Early Cancer Detection Testing at ESMO Congress 2025
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
25/09/2025
Industria
Biotecnología
Sanidad
Material médico sanitario
Salud
Oncología
ClearNote Health Receives In Vitro Diagnostic Approval in United Kingdom for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
09/07/2025
Oncología
Salud
Material médico sanitario
Medicina - Varios
Farmacéutica
Biotecnología
Industria
ClearNote Health Receives First In Vitro Diagnostic Approval for its Avantect® Pancreatic Cancer Test
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
16/06/2025
Oncología
Salud
Medicina - Varios
Farmacéutica
Biotecnología
Industria
ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients
Fuente
ClearNote Health
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0